Tenecteplase Unseats Low-Dose Alteplase Favored for Asian Patients
T-FLAVOR investigators compared tenecteplase with low-dose alteplase in stroke patients scheduled for endovascular therapy (EVT). The trial notably took place in Japanese patients, believed to be more susceptible to bleeding,…









